Clinical Trials List
Protocol Number218670
Active
2023-03-01 - 2027-11-30
Phase I/II
Recruiting2
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- MING YAO Division of General Internal Medicine
- 林昭文 Division of Ophthalmology
- Ta-Ching Chen Division of Ophthalmology
- 林耘曲 Division of Hematology & Oncology
- Sheng-chieh Chou Division of General Internal Medicine
- 柯紀綸 Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
60 participants
